Bladder Cancer

>

Latest News

Fitting ADC Therapy Into the Treatment Paradigm in Advanced Bladder Cancer
Fitting ADC Therapy Into the Treatment Paradigm in Advanced Bladder Cancer

March 14th 2024

At a live virtual event, Arlene O. Siefker-Radtke, MD, looked at the newer treatment strategies available for patients with advanced bladder cancer including sacituzumab govitecan.

Nivolumab With Chemotherapy Gains FDA Approval in Urothelial Cancer
Nivolumab With Chemotherapy Gains FDA Approval in Urothelial Cancer

March 7th 2024

Enfortumab Vedotin With Pembrolizumab Doubles Survival in Bladder Cancer
Enfortumab Vedotin With Pembrolizumab Doubles Survival in Bladder Cancer

March 6th 2024

Adjuvant Therapy in Bladder Cancer: Real-World vs Clinical Trials
Adjuvant Therapy in Bladder Cancer: Real-World vs Clinical Trials

March 4th 2024

Stable Health, Function in BCG-Unresponsive NMIBC With N-803 Plus BCG
Stable Health, Function in BCG-Unresponsive NMIBC With N-803 Plus BCG

February 6th 2024

More News